Air pollution was found to be significantly associated with an increased risk of hospital admissions for several neurological disorders, including Parkinson disease, Alzheimer disease, and other dementias.
Air pollution was found to be significantly associated with an increased risk of hospital admissions for several neurological disorders, including Parkinson disease (PD), Alzheimer disease (AD), and other dementias, according to study findings published Monday in The Lancet Planetary Health.
Led by researchers at the Harvard T.H. Chan School of Public Health, the study serves as the first nationwide analysis to examine the link between fine particulate (PM2.5) pollution and neurodegenerative diseases in the United States. As the study authors highlight, accumulating evidence links PM2.5 to premature mortality, cardiovascular disease, and respiratory disease, but less is known of its influence on neurological disorders.
Aiming to investigate the effect of PM2.5 exposure on development of PD, AD, and related dementias, researchers conducted a longitudinal study of a population-based nationwide open cohort that included all US fee-for-service Medicare beneficiaries (aged ≥ 65 years) from January 1, 2000 to December 31, 2016 (N = 63,038,019), with no exclusions. After collecting hospital admissions data from the study cohort, researchers linked each Medicare recipient with estimated PM2.5 concentrations by zip code based on mean annual predictions from a high-resolution model.
Researchers utilized Cox-equivalent Poisson models with parallel computing to estimate hazard ratios (HRs) for first hospital admission for PD or AD and related dementias, adjusting for potential confounders, such as socioeconomic status, in the health models.
Of the study cohort, researchers identified 1 million cases of PD and 3.4 million cases of AD and related dementias based on primary and secondary diagnosis billing codes. In their findings, for each 5 microgram per cubic meter of air (μg/m3) increase in annual PM2.5 concentrations, a 13% increase (HR = 1.13; 95% CI, 1.12–1.14) in risk of first-time hospital admissions for PD and AD and related dementias was observed.
Moreover, even in areas that had safe levels of PM2.5 exposure according to current US Environmental Protection Agency standards (annual average of 12 μg/m3 or less), this risk remained elevated. At-risk populations were noted to be women, white people, and urban populations, with the highest risk for first-time PD hospital admissions indicated to be among older adults in the northeastern United States. Older adults in the Midwest were shown to face the highest risk for first-time AD and related dementias hospital admissions.
"The 2020 report of the Lancet Commission on dementia prevention, intervention, and care has added air pollution as 1 of the modifiable risk factors for these outcomes," said co-lead study author Xiao Wu, doctoral student in biostatistics at Harvard T.H. Chan School of Public Health, in a statement. "Our study builds on the small but emerging evidence base indicating that long-term PM2.5 exposures are linked to an increased risk of neurological health deterioration, even at PM2.5 concentrations well below the current national standards."
Reference
Shi L, Wu X, Yazdi MD, et al. Long-term effects of PM2.5 on neurological disorders in the American Medicare population: a longitudinal cohort study. Lancet Planet Health. Published online October 19, 2020. doi:10.1016/S2542-5196(20)30227-8
Healing Wounds Through Peer Support
September 16th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this third episode, we speak with Kim MacDonald-Wilson, ScD, CPRP, and Tracy Carney, CPS, CPRP.
Listen
Insurers’ AI Denials of Postacute Care Face Senate Scrutiny
October 28th 2024Prior authorizations (PA) have been the subject of much scrutiny as of late through research demonstrating subsequent limited access to care in the aftermath of PA denials from use of artificial intelligence (AI) technologies.
Read More
Combatting the Opioid Epidemic: Insights From the Front Lines
September 2nd 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this first episode, we speak with Michael Lynch, MD, associate professor of emergency medicine at the University of Pittsburgh and an attending emergency physician and medical toxicologist at the University of Pittsburgh Medical Center.
Listen
Accountable Care Organizations and HPV Vaccine Uptake: A Multilevel Analysis
October 24th 2024The authors evaluated whether adolescents receiving care at accountable care organizations (ACOs) vs non-ACOs were more likely to initiate and complete the human papillomavirus (HPV) vaccination series.
Read More
Cost Barriers Continue to Limit Access to Fertility Care
October 24th 2024Of the 10% of women contacted for this survey who said that they or their partner had ever sought fertility assistance, only 7% were able to get the necessary care; cost was cited as the top reason for not being able to access fertility services.
Read More